Novartis (NYSE: NVS) Receives Binding Offer from Siemens Healthineers for Molecular Imaging Business
On Saturday, Novartis (NYSE: NVS), a Swiss drugmaker, said it had received a binding offer from Germany’s Siemens Healthineers to […]
Novartis
Novartis (NYSE: NVS) and Viatris (NASDAQ: VTRS) Hit with New Lawsuit Over Alleged HeLa Cell Misuse
On Monday, Novartis (NYSE: NVS) and Viatris (NASDAQ: VTRS) were hit with a federal lawsuit in Maryland by the family
Novartis (NYSE: NVS) Upgrades Profit Outlook for Second Time
FRANKFURT – Swiss drugmaker Novartis (NYSE: NVS) raised its 2024 earnings guidance for the second time on Thursday, driven by
Novartis (NYSE: NVS) Upgrades Profit Outlook for Second Time Read More »
